COMMUNICATIONS
aza-RGD mimetics showed a clear preference for the avb3
receptor.
The First Synthetic Application of a
Monooxygenase Employing Indirect
Lead structure 5 was found to exhibit a relatively high
degree of polarity; an unfavorable pharmacokinetic profile
can thus be expected for this compound. However, it has been
shown in the past that a hydrophobic residue in the b-position
to the carboxy group is tolerated by the avb3 receptor.[4d] For
this reason, we replaced the terminal carboxamide group with
a phenyl residue. The less polar RGD mimetic 10 exhibited
similar selectivity and considerably increased activity on the
avb3 receptor compared to the polar mimetic 5.
The results obtained would appear to support our concept
for identifying new, low molecular weight integrin ligands
through application of combinatorial solid-phase synthesis,
biological on-bead evaluation, and mass spectrometry to the
selected compounds.
Electrochemical NADH Regeneration**
Frank Hollmann, Andreas Schmid,* and
²
Eberhard Steckhan
In memory of Eberhard Steckhan
One of the most important challenges in applying mono-
oxygenase reactions in vitro is to find an effective regener-
ation system for the necessary co-enzyme (mostly
NAD(P)H). The well-established methods for the regener-
ation of the nicotinamide co-enzyme mainly consist of an
enzyme-coupled approach utilizing formate dehydrogena-
se[1, 4c] (for NAD(P)H) or glucose-6-phosphate dehydrogenase
(for NADPH).[2] Additionally, non-enzymatic redox catalysts
have been developed and successfully applied to NAD(P)H-
dependent dehydrogenases.[3] Thus only the producing en-
zyme and a mediator together with the electrode, as a source
of reducing equivalents, are needed.
Here we report on the first application of an isolated
monooxygenase with an indirect electrochemical regenera-
tion of NADH. The enzyme employed is the 2-hydroxybi-
phenyl-3-monooxygenase (HbpA, E.C. 1.14.13.44), a member
the class of flavine-dependent monooxygenases, from P. aze-
laica.[4] The homotetramer with a total mass of 256 kDa
catalyzes the specific ortho-hydroxylation of several a-sub-
stituted phenol derivatives (Scheme 1). To the best of our
knowledge no chemical counterpart with comparable specif-
icity is known.
Received: June 30, 2000
Revised: October 9, 2000 [Z15368]
[1] a) F. Balkenhohl, C. von dem Bussche-Hünnefeld, A. Lansky, C.
Zechel, Angew. Chem. 1996, 108, 2436 ± 2488; Angew. Chem. Int. Ed.
Engl. 1996 35, 2289 ± 2337, and references therein; b) P. Wentworth,
K. D. Janda, Curr. Opin. Biotechnol. 1998, 9, 109 ± 115, and references
therein; c) R. S. Houghten, C. Pinilla, J. R. Appel, S. E. Blondelle,
C. T. Dooley, J. Eichler, A. Nefzi, J. M. Ostresh, J. Med. Chem. 1999,
42, 3743 ± 3778, and references therein.
[2] A. Furka, F. Sebestyen, M. Asgedom, G. Dibo, Int. J. Pept. Protein Res.
1991, 37, 487 ± 493.
[3] K. S. Lam, S. E. Salmon, E. M. Hersh, V. J. Hruby, W. M. Kazmierski,
R. J. Knapp, Nature 1991, 354, 82 ± 84.
[4] a) R. Haubner, D. Finsinger, H. Kessler, Angew. Chem. 1997, 109,
1440 ± 1456; Angew. Chem. Int. Ed. Engl. 1997, 36, 1374 ± 1389, and
references therein; b) J. Samanen, Z. Jonak, D. Rieman, T.-L. Yue,
Curr. Pharm. Des. 1997, 3, 545 ± 584, and references therein; c) M. S.
Goligorsky, H. Kessler, V. I. Romanov, Nephrol. Dial. Transplant.
1998, 13, 254 ± 263, and references therein; d) R. M. Scarborough,
Curr. Med. Chem. 1999, 6, 971 ± 981, and references therein.
[5] a) E. Ruoslahti, M. D. Pierschbacher, Cell 1986, 44, 517 ± 518; b) E.
Ruoslahti, M. D. Pierschbacher, Science 1987, 238, 491 ± 497; c) T. A.
Springer, Nature 1990, 346, 425 ± 434; d) M. Pfaff in Integrin ± Ligand
Interaction (Ed.: J. A. Eble), Springer, Heidelberg, 1997, pp. 101 ± 121.
[6] a) J. Wermuth, PhD Thesis, Technische Universität München (Ger-
many), 1996; b) J. S. Schmitt, PhD Thesis, Technische Universität
München (Germany), 1998.
Scheme 1. Specific ortho-hydroxylation of a-substituted phenols catalyzed
by 2-hydroxybiphenyl-3-monooxygenase. R alkyl (Et, Pr, iPr), aryl (Ph,
2-HOC6H4), Hal (F, Cl, Br).
[7] G. B. Fields, R. L. Noble, Int. J. Pept. Protein Res. 1990, 35, 161 ± 214,
and references therein.
For the regeneration of NADH we applied the
[Cp*Rh(bpy)Cl]Cl complex which had been developed in
our group (Cp* C5Me5; bpy 2,2'-bipyridine). The corre-
sponding hydridorhodium complexes, which can be generated
either electrochemically by cathodic reduction at ꢀ750 mV
(versus Ag/AgClsat.) or chemically with formate, transform
[8] a) C. P. Holmes, J. Org. Chem. 1997, 62, 2370 ± 2380; b) C. P. Holmes,
D. G. Jones, J. Org. Chem. 1995, 60, 2318 ± 2319.
[9] For the synthesis of building blocks A3±6
, see the Supporting
Information. Although the regioisomers of compound A5 could be
separated by HPLC, they were used as a mixture of isomers for the
library synthesis.
[10] C. Gibson, S. L. Goodman, D. Hahn, G. Hölzemann, H. Kessler, J.
Org. Chem. 1999, 64, 7388 ± 7394.
NAD(P) efficiently into the enzymatically active 1,4-
NAD(P)H form[3, 5] (Scheme 2). The conversion rates
[11] Six different building blocks in group A were used for the library syn-
thesis, whereas building blocks A1 and A2 were used as a racemate and
A5 as a racemate and a mixture of regioisomers. In consideration of the
isomers in group A, 11 different building blocks have been employed.
[12] The guanylation was performed as per: Y. Wu, G. R. Matsueda, M.
Bernatowicz, Synth. Commun. 1993, 23, 2055 ± 3060; the pyrimidyla-
tion was performed as per: C. Gibson, H. Kessler, Tetrahedron Lett.
2000, 41, 1825 ± 1728.
[13] The substrate BCIP is usually used together with the oxidation agent
4-nitro-blue-tetrazolium (NBT). However, NBT proved to be incom-
patible with our libraries because it reacted with some of the resin-
bound compounds and led to false-positive results.
[*] Dr. A. Schmid, Dipl.-Chem. F. Hollmann
Institut für Biotechnologie
ETH Hönggerberg
8093 Zurich (Switzerland)
Fax : ( 41)1-633-1051
²
Prof. Dr. E. Steckhan
Institut für Organische Chemie und Biochemie
der Universität Bonn (Germany)
[**] This work was supported by BASF AG. We thank DEGUSSA AG for
the gift of chemicals.
[14] I. Ojima, S. Chakravarty, Q. Dong, Bioorg. Med. Chem. 1995, 3, 337 ±
360, and references therein.
Angew. Chem. Int. Ed. 2001, 40, No. 1
ꢀ WILEY-VCH Verlag GmbH, D-69451 Weinheim, 2001
1433-7851/01/4001-0169 $ 17.50+.50/0
169